ACKR1 and cancer: Naturally occurring variants were far more common than cancer-associated variants, with (cumulative) interface variant allele frequencies of ~31% (i.e., CCL24) and ~52% (i.e., ACKR1) for the most variable chemokines and receptors, respectively (Figure 6I; Table S4).